The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover

Condition:   Erosive Osteoarthritis Intervention:   Drug: Alendronate Effervescent Oral Tablet Sponsors:   University Hospital, Ghent;   Amgen;   EffRx Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials